Aristo Bio-Tech and Lifescience SME
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Issue details
- IPO date
- 16 Jan 2023 – 19 Jan 2023
- Listing date
- 30 Jan 2023
- Face value
- ₹10 per share
- Issue price
- ₹72 per share
- Lot size
- 1,600 shares
- Total issue size
- ₹13.05 Cr
- Market cap at offer price
- ₹49.02 Cr
- Promoter holding
- 100.00% → 73.37% pre-issue → post-issue
- ISIN
- INE082101010
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead managers
- Beeline Capital Advisors Pvt.Ltd.
- Registered office
- E-24, 25, 26, G.I.D.C.Manjusar, Ta.Savli, Gujarat
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Market maker | 91,200 | — | — |
Application size
Minimum 1,600 shares per lot, in multiples, at ₹72
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1,600 | ₹1,15,200 |
| S-HNI (min) | 2 | 3,200 | ₹2,30,400 |
| S-HNI (max) | 8 | 12,800 | ₹9,21,600 |
| B-HNI (min) | 9 | 14,400 | ₹10,36,800 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Valuation and performance
Valuation at offer price
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 2.93 | — |
| P/E (×) | 24.57 | — |
| Market cap | — | ₹49.02 Cr |
Key performance indicators
- Return on net worth
- 10.00%
- ROCE
- 35.64%
- Debt / equity
- 5.10
- PAT margin
- 0.88%
- NAV per share
- ₹29.71
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
About Aristo Bio-Tech and Lifescience SME
Aristo Bio-Tech and Lifescience Limited (ABLL) was originally incorporated on March 17, 2005 as 'Aristo Bio-Tech and Lifescience Private Limited' under the Companies Act, 1956 in Maharashtra, was converted into a public limited company vide fresh certificate of incorporation dated May 20, 2020, and shifted its registered office from Maharashtra to Gujarat (E-24, 25, 26, G.I.D.C., Manjusar, Ta. Savli, Vadodara) vide order dated November 18, 2021. The company manufactures, formulates, supplies, packages and undertakes job work for various pesticides — insecticides, herbicides, fungicides, plant growth regulators and other agrochemicals — for India and for export, with 182 products registered with the Central Insecticides Board and Registration Committee (CIB&RC). Its registered office and formulation & packaging unit are located at GIDC Estate, Manjusar, Taluka Savli, Vadodara, Gujarat, and it is ISO 9001:2015 certified. It supplies products across 20 Indian states and 15 countries, sells on a business-to-business basis to customers such as National Fertilizers Limited, HIL (India) Limited and Modern Insecticides Limited, and besides its own products provides contract manufacturing, job work and toll manufacturing services for crop protection companies; some products are also marketed by third parties under their brand names pursuant to marketing agreements. Exports were ₹453.35 Lakhs (3.51% of sales) for the period ended September 30, 2022 and ₹1,822.50 Lakhs (10.99%) in FY2022. For FY2022 the company reported total revenue of ₹16,603.29 Lakhs and profit after tax of ₹146.17 Lakhs (EPS ₹2.93), and had 55 employees on payroll as of September 30, 2022.
Company Analysis
from RHPAristo Bio-Tech and Lifescience Limited is an agrochemical company engaged in the manufacturing, formulation, supply, packaging and job work of pesticides — including insecticides, herbicides, fungicides and plant growth regulators — for the Indian and export markets.
Aristo Bio-Tech and Lifescience Limited (ABLL) was originally incorporated on March 17, 2005 as 'Aristo Bio-Tech and Lifescience Private Limited' under the Companies Act, 1956 in Maharashtra, was converted into a public limited company vide fresh certificate of incorporation dated May 20, 2020, and shifted its registered office from Maharashtra to Gujarat (E-24, 25, 26, G.I.D.C., Manjusar, Ta. Savli, Vadodara) vide order dated November 18, 2021. The company manufactures, formulates, supplies, packages and undertakes job work for various pesticides — insecticides, herbicides, fungicides, plant growth regulators and other agrochemicals — for India and for export, with 182 products registered with the Central Insecticides Board and Registration Committee (CIB&RC). Its registered office and formulation & packaging unit are located at GIDC Estate, Manjusar, Taluka Savli, Vadodara, Gujarat, and it is ISO 9001:2015 certified. It supplies products across 20 Indian states and 15 countries, sells on a business-to-business basis to customers such as National Fertilizers Limited, HIL (India) Limited and Modern Insecticides Limited, and besides its own products provides contract manufacturing, job work and toll manufacturing services for crop protection companies; some products are also marketed by third parties under their brand names pursuant to marketing agreements. Exports were ₹453.35 Lakhs (3.51% of sales) for the period ended September 30, 2022 and ₹1,822.50 Lakhs (10.99%) in FY2022. For FY2022 the company reported total revenue of ₹16,603.29 Lakhs and profit after tax of ₹146.17 Lakhs (EPS ₹2.93), and had 55 employees on payroll as of September 30, 2022.
Objects of the Issue
- To Meet Working Capital Requirement ₹935.22 Lakhs p.75
- General Corporate Expenses (General Corporate Purposes) ₹250.00 Lakhs p.76
- Public Issue Expenses ₹120.00 Lakhs p.76
Issue Structure
- Total Issue
- ₹1305.22 Lakhs (18,12,800 Equity Shares)
- Fresh Issue
- 18,12,800 Equity Shares aggregating to ₹1305.22 Lakhs (of which 91,200 Equity Shares aggregating ₹65.66 Lakhs reserved for Market Maker; Net Issue to Public 17,21,600 Equity Shares aggregating ₹1239.55 Lakhs)
- Offer for Sale
- Nil
- Price Band
- Fixed Price Issue — Issue Price of ₹72 per equity share (including share premium of ₹62 per equity share); no price band disclosed
- Lot Size
- 1,600 equity shares (minimum trading lot size)
- Face Value
- ₹10 per equity share
Business Model
Revenue is earned primarily from the manufacture and sale of agrochemical formulations (insecticides, herbicides, fungicides and plant growth regulators) on an order-driven, business-to-business basis, supplemented by contract manufacturing, job work and toll manufacturing services rendered to crop protection companies, and by export sales.
Business Segments
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| Mr. Narendra Singh Barhat | Promoter | 45.65% | 33.49% |
| Mrs. Kusum Narendra Singh Barhat | Promoter | 12.51% | 9.18% |
| Mr. Ketankumar Harkantbhai Joshi | Promoter | 14.41% | 10.58% |
| Mr. Himanshu Barhat | Promoter Group | 10.31% | 7.56% |
| Narendra Singh Barhat HUF | Promoter Group | 5.01% | 3.67% |
| Mrs. Richa N Barhat | Promoter Group | 2.50% | 1.84% |
| Mrs. Neeta Ketan Joshi | Promoter Group | 9.61% | 7.05% |
Leadership
Auto-extracted from the company's RHP using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official RHP before relying on it.